ATE64416T1 - Die verwendung des gal 1 hefe-promotors. - Google Patents
Die verwendung des gal 1 hefe-promotors.Info
- Publication number
- ATE64416T1 ATE64416T1 AT84101937T AT84101937T ATE64416T1 AT E64416 T1 ATE64416 T1 AT E64416T1 AT 84101937 T AT84101937 T AT 84101937T AT 84101937 T AT84101937 T AT 84101937T AT E64416 T1 ATE64416 T1 AT E64416T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- gal
- segment
- dna
- vector
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- CYNAPIVXKRLDER-LBPRGKRZSA-N (2s)-2-benzamido-3-(4-hydroxy-3-nitrophenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C=1C=CC=CC=1)C1=CC=C(O)C([N+]([O-])=O)=C1 CYNAPIVXKRLDER-LBPRGKRZSA-N 0.000 abstract 2
- 108010001498 Galectin 1 Proteins 0.000 abstract 2
- 102100021736 Galectin-1 Human genes 0.000 abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
- 210000000349 chromosome Anatomy 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 210000005253 yeast cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
- C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
- Y10S435/942—Saccharomyces cerevisiae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/142—Interferon
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Road Signs Or Road Markings (AREA)
- Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Devices For Indicating Variable Information By Combining Individual Elements (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/470,911 US4661454A (en) | 1983-02-28 | 1983-02-28 | GAL1 yeast promoter linked to non galactokinase gene |
EP84101937A EP0123811B1 (de) | 1983-02-28 | 1984-02-23 | Die Verwendung des GAL 1 Hefe-Promotors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE64416T1 true ATE64416T1 (de) | 1991-06-15 |
Family
ID=23869556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT84101937T ATE64416T1 (de) | 1983-02-28 | 1984-02-23 | Die verwendung des gal 1 hefe-promotors. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4661454A (de) |
EP (1) | EP0123811B1 (de) |
JP (1) | JPS6058077A (de) |
AT (1) | ATE64416T1 (de) |
CA (1) | CA1283373C (de) |
DE (1) | DE3484689D1 (de) |
DK (1) | DK97784A (de) |
GB (1) | GB2137208B (de) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0128743A3 (de) * | 1983-06-07 | 1985-12-27 | Genex Corporation | Expression von Fremdgenen in Hefe |
EP0132309A3 (de) * | 1983-06-27 | 1985-12-27 | The Board Of Trustees Of The Leland Stanford Junior University | Regulierbares eukaryotisches Promotorelement |
IL71555A (en) * | 1984-04-15 | 1992-06-21 | State Of Israel Israel Inst Fo | Bovine interferon |
US4990446A (en) * | 1984-12-06 | 1991-02-05 | Labofina, S.A. | Promoters for the expression of foreign genes in yeast, plasmids comprising them, and use thereof for the production of polypeptides |
US5037806A (en) * | 1985-02-22 | 1991-08-06 | Monsanto Company | Biologically active method using somatotropins |
US4861868A (en) | 1985-02-22 | 1989-08-29 | Monsanto Company | Production of proteins in procaryotes |
EP0225887B1 (de) * | 1985-04-08 | 1994-06-08 | Amgen Inc. | Verfahren und hybridpromotor zur steuerung der exogenen gentranskription |
JP2677350B2 (ja) * | 1985-08-02 | 1997-11-17 | メルク エンド カムパニ− インコ−ポレ−テツド | 発現蛋白の発酵収率増大 |
JPH0668B2 (ja) * | 1985-08-30 | 1994-01-05 | 財団法人化学及血清療法研究所 | 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド |
US5002876A (en) * | 1986-09-22 | 1991-03-26 | Phillips Petroleum Company | Yeast production of human tumor necrosis factor |
US5013652A (en) * | 1986-10-14 | 1991-05-07 | Genex Corporation | Composite yeast vectors |
US5882884A (en) * | 1987-06-19 | 1999-03-16 | Lucky Biotech Corporation | Expression of proteinaceous sweeteners in yeast |
US5487990A (en) * | 1988-07-01 | 1996-01-30 | The General Hospital Corporation | Glucose-regulated promoter of yeast acetyl-CoA hydrolase |
US5057419A (en) * | 1988-09-22 | 1991-10-15 | Rutgers University | Genetically engineered plasmid and organisms for the production of specialized oils |
US5187079A (en) * | 1988-12-21 | 1993-02-16 | The Research Foundation Of State University Of New York | Glucose-repressible gene for the regulated expression of proteins and expression vector therefor |
WO1991014780A1 (en) * | 1990-03-21 | 1991-10-03 | Board Of Regents, The University Of Texas System | Yeast expression vectors |
AU652576B2 (en) | 1990-09-13 | 1994-09-01 | Duke University | Expression of G protein coupled receptors in yeast |
JPH04287683A (ja) * | 1991-03-14 | 1992-10-13 | Ajinomoto Co Inc | 酵母変異株およびそれを利用するペプチドまたは蛋白質 等の製造方法 |
GB9226065D0 (en) * | 1992-12-14 | 1993-02-10 | Ici Plc | Peptides |
DE4303744A1 (de) * | 1993-02-09 | 1994-08-11 | Univ Autonoma De Nuevo Leon Mo | Hundewachstumshormon |
DE19534120A1 (de) | 1995-09-14 | 1997-03-20 | Hoechst Ag | Verwendung von Cytohesin-PH-Peptiden zur Beeinflußung der Adhäsionsfähigkeit von Integrinen |
AU1206397A (en) | 1995-12-29 | 1997-07-28 | Guilford Pharmaceuticals Inc. | Method and kit for detection of multiple protein interactions |
US5886151A (en) * | 1996-05-03 | 1999-03-23 | Regents Of The University Of Minnesota | Candida albicans integrin-like protein |
WO1998016644A1 (en) | 1996-10-16 | 1998-04-23 | Zymogenetics, Inc. | Fibroblast growth factor homologs |
US6265186B1 (en) | 1997-04-11 | 2001-07-24 | Dsm N.V. | Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces |
GB9726897D0 (en) * | 1997-12-20 | 1998-02-18 | Zeneca Ltd | Process |
JP4704565B2 (ja) | 1998-09-23 | 2011-06-15 | ザイモジェネティクス, インコーポレイテッド | サイトカインレセプターzalpha11 |
ATE404668T1 (de) | 1998-12-07 | 2008-08-15 | Zymogenetics Inc | Wachstumsfaktor-homologe zvegf-3 |
US7833529B1 (en) | 1999-01-07 | 2010-11-16 | Zymogenetics, Inc. | Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor |
ATE437227T1 (de) | 1999-01-07 | 2009-08-15 | Zymogenetics Inc | Verfahren zur therapeutischen verwendung von löslichen rezeptoren br43x2 |
EP1881070B1 (de) | 1999-03-09 | 2012-10-03 | Zymogenetics, Inc. | Menschliche Zytokine als Liganden des Z-Alpha-Rezeptors und Verwendungen davon |
ES2364086T3 (es) | 1999-07-07 | 2011-08-24 | Zymogenetics, Inc. | Receptor de citoquina humana. |
EP2194130A1 (de) | 1999-12-23 | 2010-06-09 | ZymoGenetics, L.L.C. | Zytokin ZCYT018 |
EP1278852B1 (de) | 2000-05-11 | 2010-07-07 | ZymoGenetics, Inc. | Zsig33-ähnliche peptide |
AU2001273032A1 (en) | 2000-06-26 | 2002-01-08 | Zymogenetics Inc. | Cytokine receptor zcytor17 |
ATE404670T1 (de) | 2000-06-30 | 2008-08-15 | Zymogenetics Inc | Allelische variante des interferon-ähnlichen proteins zcyto21 |
EP1736545A3 (de) | 2000-08-08 | 2007-03-28 | ZymoGenetics, Inc. | Lösliche Zcyctor 11 Cytokinrezeptoren |
WO2002053747A1 (en) * | 2000-12-28 | 2002-07-11 | Toyota Jidosha Kabushiki Kaisha | Process for producing prenyl alcohol |
EP2301971A1 (de) | 2001-02-20 | 2011-03-30 | ZymoGenetics, L.L.C. | Antikörper, die sowohl BCMA als auch TACI binden |
PT1436003E (pt) | 2001-05-24 | 2010-03-12 | Zymogenetics Inc | Proteínas de fusão imunoglobulina taci |
AU2002336676A1 (en) | 2001-11-05 | 2003-05-19 | Zymogenetics, Inc | Il-21 antagonists |
PL211833B1 (pl) | 2002-01-18 | 2012-06-29 | Zymogenetics Inc | Wyizolowany polipeptyd, białko fuzyjne, wyizolowana cząsteczka polinukleotydu, wektor ekspresji, hodowana komórka, sposób wytwarzania polipeptydu, sposób wytwarzania przeciwciała, przeciwciało, przeciwciało lub fragment przeciwciała, zastosowanie przeciwciała, sposób wykrywania obecności polipeptydu, sposób inhibicji proliferacji lub różnicowania komórek krwiotwórczych, zastosowanie polipeptydu, sposób rozprzestrzeniania komórek krwiotwórczych, sposób wykrywania obecności RNA, sposób zabijania komórek nowotworowych in vitro lub in vivo, zastosowanie polipeptydu, zastosowanie antagonisty polipeptydu i sposób wykrywania zapalenia u pacjenta |
PT1576112E (pt) | 2002-01-18 | 2012-05-25 | Zymogenetics Inc | Multímeros de receptor de citocina zcytor17 |
BR0309401A (pt) | 2002-04-19 | 2007-02-21 | Zymogenetics Inc | polinucleotìdeo isolado, vetor de expressão, célula cultivada, método para produzir polipeptìdeos, e um anticorpo para um polipeptìdeo, e, anticorpo |
US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
US7785871B2 (en) * | 2002-10-09 | 2010-08-31 | Intrexon Corporation | DNA cloning vector plasmids and methods for their use |
US20080050808A1 (en) * | 2002-10-09 | 2008-02-28 | Reed Thomas D | DNA modular cloning vector plasmids and methods for their use |
ES2303132T3 (es) | 2003-08-07 | 2008-08-01 | Zymogenetics, Inc. | Preparaciones homogeneas de il-29. |
CN1283792C (zh) * | 2003-11-14 | 2006-11-08 | 余伟明 | 生物大分子组分相分离法 |
WO2005087810A2 (en) | 2004-03-08 | 2005-09-22 | Zymogenetics, Inc. | Dimeric fusion proteins and materials and methods for producing them |
ES2603062T3 (es) * | 2004-05-18 | 2017-02-23 | Intrexon Corporation | Métodos de ensamblaje dinámico de vectores para la clonación de ADN de vectores plasmídicos |
CN101829318B (zh) | 2004-07-29 | 2012-07-04 | 津莫吉尼蒂克斯有限责任公司 | Il-28和il-29治疗癌症和自身免疫性疾病的用途 |
EP2166103B1 (de) | 2004-08-02 | 2013-05-22 | BASF Plant Science GmbH | Verfahren zur Isolierung von Transkriptionsabschlusssequenzen |
CA2596390A1 (en) | 2005-02-08 | 2006-08-17 | Zymogenetics, Inc. | Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
ATE515512T1 (de) | 2005-05-12 | 2011-07-15 | Zymogenetics Inc | Zusammensetzungen und verfahren zur modulierung von immunreaktionen |
AU2006278227B2 (en) | 2005-08-09 | 2011-10-20 | Ares Trading S.A. | Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules |
WO2007019575A2 (en) * | 2005-08-09 | 2007-02-15 | Zymogenetics, Inc. | Methods for treating b-cell malignancies using taci-ig fusion molecule |
US8153598B2 (en) * | 2005-10-19 | 2012-04-10 | Intrexon Corporation | PKD ligands and polynucleotides encoding PKD ligands |
AU2007249223B2 (en) * | 2006-05-15 | 2012-08-02 | Ares Trading S.A. | Methods for treating autoimmune diseases using a TACI-Ig fusion molecule |
US20100240597A1 (en) | 2007-06-15 | 2010-09-23 | Arkansas State University | Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same |
US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
AU2008298603B2 (en) | 2007-09-14 | 2015-04-30 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
CN103059118B (zh) | 2007-11-21 | 2017-11-24 | 罗斯基勒大学 | 具有冰结合活性的多肽 |
WO2009080054A1 (en) * | 2007-12-21 | 2009-07-02 | Ifxa A/S | Protease inhibitor |
BRPI0907640A2 (pt) * | 2008-01-25 | 2015-11-03 | Univ Aarhus | inibição exosítio-seletiva da atividade de papp-a contra igfbp-4 |
EP2604279A1 (de) | 2008-03-27 | 2013-06-19 | ZymoGenetics, Inc. | Zusammensetzungen und Verfahren zur Hemmung von PDGFR-beta und VEGF-A |
EP2313105B1 (de) | 2008-06-27 | 2013-07-24 | ZymoGenetics, Inc. | LÖSLICHE HYBRID-Fc gamma-REZEPTOREN UND ENTSPRECHENDE VERFAHREN |
BR112012031329A2 (pt) | 2010-06-09 | 2016-10-11 | Zymogenetics Inc | proteínas de fusão diméricas vstm3 e composições e métodos relacionados |
EP3597764A3 (de) | 2012-02-01 | 2020-05-06 | SGI-DNA, Inc. | Material und verfahren zur synthese von fehlerminimierten nukleinsäuremolekülen |
WO2014202089A2 (en) | 2013-06-18 | 2014-12-24 | Roskilde Universitet | Variants of anti-freeze polypeptides |
CN106318942B (zh) * | 2015-06-29 | 2018-12-25 | 中国科学院大连化学物理研究所 | 一种半乳糖激酶启动子和终止子及其应用 |
CN106318943B (zh) * | 2015-06-29 | 2019-03-05 | 中国科学院大连化学物理研究所 | 半乳糖激酶启动子和终止子及其应用 |
DK3328881T3 (da) | 2015-09-08 | 2019-10-07 | Theripion Inc | Apoa-1 fusionspolypeptider og relaterede sammensætninger og fremgangsmåder |
WO2018136163A2 (en) | 2016-12-09 | 2018-07-26 | Theripion, Inc. | Tandem apoa-1 fusion polypeptides |
KR102649757B1 (ko) | 2017-07-20 | 2024-03-21 | 압테보 리서치 앤드 디벨롭먼트 엘엘씨 | 5t4 및 4-1bb에 결합하는 항원 결합 단백질 및 관련 조성물 및 방법 |
CA3085861C (en) | 2017-12-20 | 2023-09-26 | Harbour Biomed (Shanghai) Co., Ltd | Antibodies binding ctla-4 and uses thereof |
WO2019132765A1 (en) | 2017-12-27 | 2019-07-04 | Imunami Laboratories Pte. Ltd. | Recombinant polypeptides and methods of use thereof |
US10150801B1 (en) | 2017-12-27 | 2018-12-11 | Imunami Laboratories Pte. Ltd. | Recombinant polypeptides and methods of use thereof |
US10675332B1 (en) | 2019-08-26 | 2020-06-09 | Imunami Laboratories Pte. Ltd. | Recombinant polypeptides and methods of use thereof |
WO2021040610A1 (en) | 2019-08-26 | 2021-03-04 | Imunami Laboratories Pte. Ltd. | Recombinant polypeptides and methods of use thereof |
JP2023538476A (ja) | 2020-06-22 | 2023-09-08 | イミュナミ ラボラトリーズ プライベート リミティド | 癌治療における使用のための組換えポリペプチド及び組合せ |
AU2022224584A1 (en) | 2021-02-19 | 2023-09-21 | Theripion, Inc. | Paraoxonase fusion polypeptides and related compositions and methods |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4443539A (en) * | 1980-02-05 | 1984-04-17 | The Upjohn Company | Process for preparing bovine growth hormone |
US4666847A (en) * | 1981-01-16 | 1987-05-19 | Collaborative Research, Inc. | Recombinant DNA means and method |
NZ199722A (en) * | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
EP0128743A3 (de) * | 1983-06-07 | 1985-12-27 | Genex Corporation | Expression von Fremdgenen in Hefe |
EP0132309A3 (de) * | 1983-06-27 | 1985-12-27 | The Board Of Trustees Of The Leland Stanford Junior University | Regulierbares eukaryotisches Promotorelement |
-
1983
- 1983-02-28 US US06/470,911 patent/US4661454A/en not_active Expired - Lifetime
-
1984
- 1984-02-23 DE DE8484101937T patent/DE3484689D1/de not_active Expired - Lifetime
- 1984-02-23 AT AT84101937T patent/ATE64416T1/de not_active IP Right Cessation
- 1984-02-23 EP EP84101937A patent/EP0123811B1/de not_active Expired - Lifetime
- 1984-02-24 DK DK97784A patent/DK97784A/da not_active Application Discontinuation
- 1984-02-27 CA CA000448315A patent/CA1283373C/en not_active Expired - Lifetime
- 1984-02-28 GB GB08405129A patent/GB2137208B/en not_active Expired
- 1984-02-28 JP JP59035472A patent/JPS6058077A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA1283373C (en) | 1991-04-23 |
DK97784A (da) | 1984-08-29 |
US4661454A (en) | 1987-04-28 |
JPS6058077A (ja) | 1985-04-04 |
EP0123811A3 (en) | 1986-03-26 |
GB8405129D0 (en) | 1984-04-04 |
EP0123811A2 (de) | 1984-11-07 |
DK97784D0 (da) | 1984-02-24 |
EP0123811B1 (de) | 1991-06-12 |
GB2137208A (en) | 1984-10-03 |
GB2137208B (en) | 1987-05-13 |
DE3484689D1 (de) | 1991-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE64416T1 (de) | Die verwendung des gal 1 hefe-promotors. | |
ATE111156T1 (de) | Transientes expressionssystem zur herstellung von rekombinantem protein. | |
ES8602138A1 (es) | Metodo de controlar la expresion de un gen que codifica una proteinaheterologa deseada. | |
SE8007998L (sv) | Forfarande for framstellning av interferon | |
KR920012442A (ko) | 피치아 파스토리스 산성 인산효소 유전자의 dna 단편 및 이를 사용하는 방법 | |
DE3888561T2 (de) | Hohe Proteinsyntheserate in Hefe. | |
DK0378382T3 (da) | Rekombinant DNA-fremgangsmåde og værtsceller | |
DK102886D0 (da) | Proteinfaktorer | |
DE69331908D1 (de) | Verfahren zur erhöhung der expression und zur verminderung der expressionsvariabilität von fremdgenen in pflanzenzellen | |
Huttner et al. | DNA-mediated gene transfer without carrier DNA. | |
ATE67242T1 (de) | Verfahren zur verbesserung der expression von eukaryontenprotein. | |
ES2013353A6 (es) | Metodo de adn recombonante para producir proteinas fijadoras de oxigeno, particularmente hemoglobinas. | |
DK0749489T3 (da) | Ekspressionskassette, der omfatter en promotor stammende fra pho4-genet fra Schizosaccharomyces pombe | |
DE69023101D1 (de) | Bakterielles Kollagenase-Gen. | |
ATE90386T1 (de) | Verfahren zur expression von genen in hefe, dns- fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden. | |
DE58909205D1 (de) | Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten. | |
ATE107358T1 (de) | System der induzierbaren positiven regulation zur verwendung für die herstellung von heterologen proteinen. | |
ATE85358T1 (de) | Verfahren zur herstellung von plasminogenaktivatoren in prokaryonten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |